These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
66 related articles for article (PubMed ID: 11428597)
21. OKT3 induction and steroid-free maintenance immunosuppression for treatment of high-risk heart transplant recipients. Prieto M; Lake KD; Pritzker MR; Jorgensen CR; Arom KV; Love KR; Emery RW J Heart Lung Transplant; 1991; 10(6):901-11. PubMed ID: 1661608 [TBL] [Abstract][Full Text] [Related]
22. A prospective randomized controlled study on the efficacy and tolerance of two antilymphocytic globulins in the prevention of rejection in first-heart transplant recipients. Schnetzler B; Leger P; Völp A; Dorent R; Pavie A; Gandjbakhch I Transpl Int; 2002 Jun; 15(6):317-25. PubMed ID: 12072903 [TBL] [Abstract][Full Text] [Related]
23. Effects of methotrexate on acute rejection and cardiac allograft vasculopathy in heart transplant recipients. Costanzo MR; Koch DM; Fisher SG; Heroux AL; Kao WG; Johnson MR J Heart Lung Transplant; 1997 Feb; 16(2):169-78. PubMed ID: 9059928 [TBL] [Abstract][Full Text] [Related]
27. Influence of preoperative transpulmonary gradient on late mortality after orthotopic heart transplantation. Erickson KW; Costanzo-Nordin MR; O'Sullivan EJ; Johnson MR; Zucker MJ; Pifarré R; Lawless CE; Robinson JA; Scanlon PJ J Heart Transplant; 1990; 9(5):526-37. PubMed ID: 2231091 [TBL] [Abstract][Full Text] [Related]
28. The potential role of T-cell memory distribution as predisposing factor for rejection in heart transplant recipients. Lanio N; Sarmiento E; Gallego A; Fernández-Yánez J; Palomo J; Pérez-Rojas J; Carbone J Transplant Proc; 2009; 41(6):2480-4. PubMed ID: 19715957 [TBL] [Abstract][Full Text] [Related]
29. Repeated measurements of NT-pro-B-type natriuretic peptide, troponin T or C-reactive protein do not predict future allograft rejection in heart transplant recipients. Battes LC; Caliskan K; Rizopoulos D; Constantinescu AA; Robertus JL; Akkerhuis M; Manintveld OC; Boersma E; Kardys I Transplantation; 2015 Mar; 99(3):580-5. PubMed ID: 25136844 [TBL] [Abstract][Full Text] [Related]
30. Methotrexate therapy for complex graft rejection in pediatric heart transplant recipients. The Pediatric Heart Transplant Team--Loma Linda. Chinnock R; Emery J; Larsen R; Baum M; Janner D; Razzouk A; Gundry S; Nehlsen-Cannarella S; Bailey L J Heart Lung Transplant; 1995; 14(4):726-33. PubMed ID: 7578182 [TBL] [Abstract][Full Text] [Related]
31. Combined antiviral and immunoglobulin therapy as prophylaxis against cytomegalovirus infection after heart transplantation. Valenza M; Czer LS; Pan SH; Aleksic I; Freimark D; Harasty DA; Admon D; Barath P; Blanche C; Trento A J Heart Lung Transplant; 1995; 14(4):659-65. PubMed ID: 7578172 [TBL] [Abstract][Full Text] [Related]
32. Effect of late medication non-compliance on outcome after heart transplantation: a 5-year follow-up. Dobbels F; De Geest S; van Cleemput J; Droogne W; Vanhaecke J J Heart Lung Transplant; 2004 Nov; 23(11):1245-51. PubMed ID: 15539122 [TBL] [Abstract][Full Text] [Related]
33. Methotrexate or total lymphoid radiation for treatment of persistent or recurrent allograft cellular rejection: a comparative study. Ross HJ; Gullestad L; Pak J; Slauson S; Valantine HA; Hunt SA J Heart Lung Transplant; 1997 Feb; 16(2):179-89. PubMed ID: 9059929 [TBL] [Abstract][Full Text] [Related]
34. Low-dose tacrolimus/sirolimus and steroid withdrawal in heart recipients is highly efficacious. Meiser B; Kaczmarek I; Mueller M; Groetzner J; Weis M; Knez A; Stempfle HU; Klauss V; Schmoeckel M; Reichart B; Ueberfuhr P J Heart Lung Transplant; 2007 Jun; 26(6):598-603. PubMed ID: 17543783 [TBL] [Abstract][Full Text] [Related]
35. Tuberculosis after heart transplantation: twenty years of experience in a single center in Taiwan. Chou NK; Wang JL; Chi NH; Wu IH; Huang SC; Chen YS; Yu HY; Tsao CI; Ko WJ; Su HY; Chang SC; Chu SH; Wang SS Transplant Proc; 2008 Oct; 40(8):2631-3. PubMed ID: 18929823 [TBL] [Abstract][Full Text] [Related]